Metanalysis of 1st line TNFi survival:
12 mos 24 mos 36 mos
ETN 71% 63% 59%
IFX 69% 57% 49%
ADA 70% 59% 51%
Does ETN have better survival? https://t.co/T4QVbI5lf7 https://t.co/mqsaADb7Uu
Links:
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rhe…
https://bit.ly/2yuIor8
Apr-22-2020
